Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy
- PMID: 3105138
Item in Clipboard
Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy
Transplant Proc.
1987 Apr.
No abstract available
Similar articles
-
Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.Transplant Proc. 1987 Apr;19(2 Suppl 1):28-31. Transplant Proc. 1987. PMID: 3105137 Clinical Trial. No abstract available.
-
Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.J Heart Transplant. 1989 Jul-Aug;8(4):281-7. J Heart Transplant. 1989. PMID: 2504894
-
Treatment with OKT3 and cyclosporine for acute allograft rejection.Transplant Proc. 1991 Aug;23(4):2119-22. Transplant Proc. 1991. PMID: 1908150
-
Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.East Afr Med J. 1990 Sep;67(9):667-73. East Afr Med J. 1990. PMID: 2123786 Review.
-
Clinical development of Orthoclone OKT3.Transplant Proc. 1987 Apr;19(2 Suppl 1):7-16. Transplant Proc. 1987. PMID: 3105142 Review. No abstract available.
Cited by
-
The role of OKT3 in clinical transplantation.Pediatr Nephrol. 1991 Jan;5(1):130-6. doi: 10.1007/BF00852870. Pediatr Nephrol. 1991. PMID: 1827342 Review.
-
Muromonab CD3. A review of its pharmacology and therapeutic potential.Drugs. 1989 Jun;37(6):871-99. doi: 10.2165/00003495-198937060-00004. Drugs. 1989. PMID: 2503348 Review.
-
Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.Clin Exp Immunol. 2003 Sep;133(3):485-92. doi: 10.1046/j.1365-2249.2003.02200.x. Clin Exp Immunol. 2003. PMID: 12930378 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical